Foundry Partners LLC purchased a new stake in Perrigo Company plc (NYSE:PRGO – Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 271,090 shares of the company’s stock, valued at approximately $7,111,000.
Other large investors have also bought and sold shares of the company. Diamond Hill Capital Management Inc. boosted its stake in shares of Perrigo by 83.2% in the 2nd quarter. Diamond Hill Capital Management Inc. now owns 1,940,067 shares of the company’s stock worth $49,821,000 after buying an additional 881,191 shares during the last quarter. AQR Capital Management LLC boosted its position in Perrigo by 675.5% in the second quarter. AQR Capital Management LLC now owns 970,637 shares of the company’s stock worth $24,926,000 after purchasing an additional 845,470 shares during the last quarter. National Bank of Canada FI bought a new position in Perrigo in the 1st quarter valued at $19,040,000. Copeland Capital Management LLC raised its stake in shares of Perrigo by 23.1% during the 3rd quarter. Copeland Capital Management LLC now owns 2,482,544 shares of the company’s stock worth $65,117,000 after purchasing an additional 465,161 shares during the period. Finally, Deprince Race & Zollo Inc. boosted its holdings in shares of Perrigo by 11.2% in the 2nd quarter. Deprince Race & Zollo Inc. now owns 3,882,438 shares of the company’s stock worth $99,701,000 after buying an additional 391,646 shares during the last quarter. 95.91% of the stock is currently owned by institutional investors.
Insider Buying and Selling
In other news, Director Katherine C. Doyle sold 8,954 shares of the company’s stock in a transaction dated Friday, September 13th. The stock was sold at an average price of $27.30, for a total value of $244,444.20. Following the completion of the transaction, the director now directly owns 6,009 shares in the company, valued at approximately $164,045.70. This represents a 59.84 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Ronald Craig Janish sold 13,000 shares of the company’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $29.40, for a total transaction of $382,200.00. Following the completion of the sale, the executive vice president now directly owns 20,553 shares of the company’s stock, valued at $604,258.20. This trade represents a 38.74 % decrease in their position. The disclosure for this sale can be found here. 0.70% of the stock is owned by company insiders.
Analyst Ratings Changes
View Our Latest Research Report on Perrigo
Perrigo Stock Performance
Shares of PRGO stock opened at $27.15 on Thursday. The company’s fifty day simple moving average is $25.98 and its two-hundred day simple moving average is $27.17. Perrigo Company plc has a 1 year low of $23.89 and a 1 year high of $34.60. The company has a debt-to-equity ratio of 0.94, a current ratio of 2.56 and a quick ratio of 1.77.
Perrigo (NYSE:PRGO – Get Free Report) last issued its quarterly earnings data on Wednesday, November 6th. The company reported $0.81 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.81. The business had revenue of $1.09 billion for the quarter, compared to analysts’ expectations of $1.12 billion. Perrigo had a positive return on equity of 7.38% and a negative net margin of 3.64%. The firm’s quarterly revenue was down 3.2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.64 EPS. As a group, equities research analysts anticipate that Perrigo Company plc will post 2.56 earnings per share for the current year.
Perrigo Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Friday, November 29th will be issued a dividend of $0.276 per share. This represents a $1.10 annualized dividend and a dividend yield of 4.07%. The ex-dividend date of this dividend is Friday, November 29th. Perrigo’s payout ratio is -94.02%.
About Perrigo
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.
Featured Articles
- Five stocks we like better than Perrigo
- Investing In Automotive Stocks
- Lowe’s Stock Dip: Don’t Miss This Second-Chance Entry Point
- Canadian Penny Stocks: Can They Make You Rich?
- Tailwinds Drive Walmart Higher, Uptrend Shows No Signs of Slowing
- Trading Stocks: RSI and Why it’s Useful
- Is Biotech’s Bull Run Over? Examining Election Impacts
Want to see what other hedge funds are holding PRGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Perrigo Company plc (NYSE:PRGO – Free Report).
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.